NCT02268396 - Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD | Biotech Hunter

Enrollment

138

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

May 31, 2015

Conditions

COPD

Interventions

DRUG

Glycopyrronium and Formoterol Fumarate Metered-dose Inhaler

GFF MDI administered as 2 inhalations BID

Trial Locations (10)

Pearl Investigative Site, Clearwater

Pearl Investigative Site, Tampa

Pearl Investigative Site, Winter Park

Pearl Investigative Site, Charlotte

Pearl Investigative Site, Columbus

Pearl Investigative Site, Medford

Pearl Investigative Site, Greenville

Pearl Investigative Site, Rock Hill

Pearl Investigative Site, Spartanburg

Pearl Investigative Site, Richmond